BIOSERENTACH

bioserentach-logo

BioSerenTach Inc delivers antigens directly to Langerhans cells of the immune system.

#People #Website #More

BIOSERENTACH

Industry:
Biotechnology Health Care

Founded:
2001-01-01

Address:
Kyoto, Kyoto, Japan

Country:
Japan

Website Url:
http://www.bioserentach.co.jp

Status:
Active

Contact:
075-746-2160

Email Addresses:
[email protected]

Technology used in webpage:
SPF Apache GMO Internet Lolipop Lolipop DNS


Current Employees Featured

kanji-takada_image

Kanji Takada
Kanji Takada Executive chairman @ BioSerenTach
Executive chairman

Official Site Inspections

http://www.bioserentach.co.jp

  • Host name: 118-27-125-206.virt.lolipop.jp
  • IP address: 118.27.125.206
  • Location: Tokyo Japan
  • Latitude: 35.6882
  • Longitude: 139.7532
  • Timezone: Asia/Tokyo
  • Postal: 102-0082

Loading ...

More informations about "BioSerenTach"

BioSerenTach (BT)

BioSerenTach has the original innovative drug delivery technologies and provides the pharmaceutical companies with the drug delivery systems to develop and commercialize new …See details»

Contact us - bioserentach.co.jp

BioSerenTach Inc. Head office: Shimizu-cho 389, Nakagyo-ku, Kyoto 604-0874, Japan: Tel: 075-746-2160 (from abroad 81-75-746-2160) Fax : 075-746-2160 (from abroad 81-75-746-2160)See details»

BIOSERENTACH INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for BIOSERENTACH INC. of KYOTO, KYOTO. Get the latest business insights from Dun & …See details»

BioSerenTach - VentureRadar

Kindeva Drug Delivery USA Privately Held Kindeva is the pharmaceutical contract development and manufacturing organization (CDMO) that brings the expertise, vision, and capabilities to …See details»

Contact us - BioSerenTach

Dr. Takada retired Kyoto Pharmaceutical University on March 31, 2014 and now works in BioSerenTach. Professor Dr. Kanji Takada Head Office Address Shimizu-cho 389, Nakagyo …See details»

BioSerenTach - Crunchbase Company Profile & Funding

BioSerenTach Inc delivers antigens directly to Langerhans cells of the immune system. ... Solutions. Products. Resources. Pricing. Resources. Log In. Organization. BioSerenTach . …See details»

BioSerenTach Inc. - Products, Competitors, Financials, Employees ...

Microneedle Drug Delivery Systems Global Market Research Report 2022 - ResearchAndMarkets.com. Jun 3, 2022. June 03, 2022 10:30 AM Eastern Daylight Time …See details»

BioSerenTach - Overview, News & Similar companies - ZoomInfo

View BioSerenTach (www.bioserentach.co.jp) location in Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»

BioSerenTach, Inc. (BioSerenTach, Inc.) - 药物管线_专利_临床试验_ …

ABSTRACT Recent clinical trials showed a prolonged retention of subinhibitory concentrations of unbound azithromycin in the interstitial fluid of soft tissues despite the fact that azithromycin is …See details»

BIOSERENTACH CO., LTD. - US Patent and Trademark Search

BIOSERENTACH CO., LTD. - Kyoto-shi, Kyoto JP; BIOSERENTACH CO., LTD. - Kyoto-shi JP *profile and listings may contain filings by different individuals or companies with the same …See details»

EU-Japan Biotech & Pharma Partnering Conference 2024

BioSerenTach Co. Jp. B. BioSerenTach Co. Jp. Company. Kyoto, Japan. Overview. About. BioSerenTach started in 2001 when Prof. Takada was at Kyoto Pharmaceutical University to …See details»

Bio Venture Directory BioSerenTach Inc. - area34.smp.ne.jp

Aug 1, 2001 ・BST is looking for a co-developer on b-FGF DM array chip for the regeneration of the skin, anti-aging. ・Looking for pharmaceutical companies to co-develop GI-MAPS for oral delivery of macromolecular drugs. ・Looking for licensee ・Looking for companies to co-develop DMs as skin vaccine.See details»

BioSerenTach - Tech Stack, Apps, Patents & Trademarks

BioSerenTach Inc delivers antigens directly to Langerhans cells of the immune system.See details»

BIOSERENTACH CO., LTD., Patent Owner, KYOTO, JP

View BIOSERENTACH CO., LTD.'s, KYOTO, JP, patent portfolio profile on Patent Buddy. Patent Buddy is the world's most extensive database and networking website for patent attorneys, …See details»

Contact us - bioserentach.co.jp

Https://shotmode.jp ・NEEDROP by NISSHA Co., Ltd., from 2020 ... ・ BioSerenTach had an exhibition booth in Japan Healthcare Venture Summit, Yokohama. ・VC microN Patch was …See details»

BioSerenTach Inc. - CMOCRO

BioSerenTach has the original innovative drug delivery technologies and provides the pharmaceutical companies with the drug delivery systems to develop and commercialize new …See details»

Patents Assigned to BIOSERENTACH CO., LTD.

Jun 22, 2018 Assignee: BIOSERENTACH CO., LTD. Inventor: Kanji Takada VACCINE ADJUVANT AND MICRONEEDLE PREPARATION. Publication number: 20200215187 …See details»

Company Details :: HBW Insight

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183See details»

Our DDS Technologies - BioSerenTach

BioSerenTach (BT) is now developing “Dissolving Micropile Chip” that gives a solution to pharmaceutical industries, poor bioavailability problem of API. Dissolving micropile (DM) is a …See details»

Our DDS Technologies - bioserentach.co.jp

By comparing to the iv data, the BA of desmopressin from GI-MAPS was 46%, though the BA from co-administration with absorption enhancer was 10 %.G-CSF (125 microgram) loaded GI …See details»